Brian E. Fink
Impact in
- Toxicology top 2%
- Organic Chemistry top 2%
- Synthesis and biological activity
Papers in
- Oncology 16
- HER2/EGFR in Cancer Research 10
-
- Chemical Synthesis and Analysis 5
- Cancer therapeutics and mechanisms 4
- DNA and Nucleic Acid Chemistry 3
- TGF-β signaling in diseases 2
- Co-authors
- Michael P. Hedrick (5 shared papers)Dale L. Boger (5 shared papers)John A. Katzenellenbogen (3 shared papers)Steven R. Brunette (1 shared paper)Winston C. Tse (1 shared paper)Jun Sun (1 shared paper)Benita S. Katzenellenbogen (1 shared paper)Ramji Ramaswamy Rajendran (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Journal of the American Chemical Society (3 papers)Journal of Medicinal Chemistry (3 papers)The Journal of Organic Chemistry (2 papers)ACS Medicinal Chemistry Letters (2 papers)
- Partner nations
- United StatesGermanySweden
In The Last Decade
Brian E. Fink
33 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 91
- Toxicology 113
- Organic Chemistry 762
- Oncology 516
- Molecular Biology 1.0k
- Genetics 365
Countries citing papers authored by Brian E. Fink
This map shows the geographic impact of Brian E. Fink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian E. Fink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian E. Fink more than expected).
Fields of papers citing papers by Brian E. Fink
This network shows the impact of papers produced by Brian E. Fink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian E. Fink. The network helps show where Brian E. Fink may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian E. Fink, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 503 | |
| 2 | 1999 | 288 | |
| 3 | 1999 | 202 | |
| 4 | 2000 | 170 | |
| 5 | 1998 | 91 | |
| 6 | 2004 | 86 | |
| 7 | 2006 | 72 | |
| 8 | 2005 | 42 | |
| 9 | 2006 | 37 | |
| 10 | 2007 | 35 | |
| 11 | 2018 | 34 | |
| 12 | 2001 | 30 | |
| 13 | 2007 | 29 | |
| 14 | 2009 | 29 | |
| 15 | 2018 | 28 | |
| 16 | 2022 | 27 | |
| 17 | 2000 | 25 | |
| 18 | 2010 | 25 | |
| 19 | 2007 | 21 | |
| 20 | 2019 | 21 |
About Brian E. Fink
Brian E. Fink is a scholar working on Oncology, Molecular Biology, Immunology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Chemical Synthesis and Analysis (5 papers), Estrogen and related hormone effects (4 papers), Cancer therapeutics and mechanisms (4 papers), DNA and Nucleic Acid Chemistry (3 papers), Synthetic Organic Chemistry Methods (2 papers) and TGF-β signaling in diseases (2 papers). The work is most often cited by research in Toxicology (113 citations), Organic Chemistry (762 citations), Oncology (516 citations), Molecular Biology (1.0k citations) and Genetics (365 citations). Brian E. Fink has collaborated with scholars based in United States, Germany and Sweden. Frequent co-authors include Michael P. Hedrick, Dale L. Boger, John A. Katzenellenbogen, Steven R. Brunette, Winston C. Tse, Jun Sun, Benita S. Katzenellenbogen, Ramji Ramaswamy Rajendran, Marvin J. Meyers and Shaun R. Stauffer. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society, Journal of Medicinal Chemistry, The Journal of Organic Chemistry and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.